Silo Pharma (SILO) Equity Income (2017 - 2018)
Silo Pharma (SILO) posted Equity Income of -$198162.0 for Q3 2018, up 61.83% sequentially from -$519143.0 in Q3 2017, and up 61.83% YoY from -$122451.5 in Q3 2017.
Silo Pharma (SILO) Equity Income (2017 - 2018) Analysis & Trends
Silo Pharma has reported Equity Income for 2 years, with the latest figure at -$198162.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.08 Mn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -198,162.00 |
| Sep 30, 2017 | -519,143.00 |